Oncogenomics and the development of new cancer therapies - Test2 - elhamkhani - TriplyDB

Oncogenomics and the development of new cancer therapies

Oncogenomics and the development of new cancer therapies

http://www.wikidata.org/entity/Q28263634

about

Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90 Identification of cancer genes by mutational profiling of tumor genomes Evolutionary concepts in biobanking - the BC BioLibrary An Empirical Evaluation of Normalization Methods for MicroRNA Arrays in a Liposarcoma Study Differences in the binding affinities of ErbB family: heterogeneity in the prediction of resistance mutants Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.Molecular targeting of glioblastoma: Drug discovery and therapies Prostate cancer regulatory networks Cancer driver mutations in protein kinase genes Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases.Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.Developing drugs for cognitive impairment in schizophrenia.Incorporating the human gene annotations in different databases significantly improved transcriptomic and genetic analyses Targeting the human cancer pathway protein interaction network by structural genomics.Functional proteomics: application of mass spectrometry to the study of enzymology in complex mixtures.In silico polypharmacology of natural products.Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.Human cancer classification: a systems biology- based model integrating morphology, cancer stem cells, proteomics, and genomics.Shock the heat shock network.Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis.An integrative analysis of microRNA and mRNA expression--a case study.

P2860

Q24647585-AF89A02D-CAF4-4623-9017-623A3FF2AF22 Q28239452-2A45C768-D8F3-4757-B8DB-7E71BF80F3E7 Q28392339-7F52B89E-5230-485E-B9A9-C152EF06485B Q28396443-9F8D7A66-4DE0-49C5-80E6-A49216C49E00 Q28534601-19FC876E-6EEE-43A6-BE78-ABCF9EA27E89 Q30157152-375E381F-F168-4978-AF70-E9ED3F318F46 Q33911283-F10D83D3-C64F-4CE6-BC71-600FFE9BC996 Q33960568-A8131AD5-6EFF-4E31-9545-F641918CEDCC Q34002709-B30B1E77-ADC4-491B-BF96-D63855BBC88C Q35128103-F6150164-03B2-4CE5-B835-961A59C8E4DF Q35161318-EE6E2D50-EF4B-4FF2-99FC-1ED5D03D81C7 Q35613117-26796289-C27B-4F42-B2CF-7A1F2BB59DE2 Q35648261-9A56A5FB-C743-46A1-954A-285B55B01128 Q36252785-60302A47-17B6-4C55-B97D-1883548B3D27 Q36915043-84C26C2D-1EFD-4334-AFB1-C2068A2DD7F7 Q36919983-A92A042A-01C4-40A9-953E-AB0CDE32C663 Q37902554-6E9F2C39-6D9E-4B43-9822-5552EC691B23 Q38810969-26EF9241-5C11-4692-9C88-10CA235156A3 Q39671016-17919B38-C71B-4618-AE8C-C0BA09FDC193 Q39762235-E33B63B7-7801-48A4-B056-CE58BF955C96 Q39869511-25D26321-2A09-42EB-92B7-D879307FD76C Q41959007-8343C1EF-D44F-4F84-AD79-55D6D5E69B9D Q42064838-72AAEC1D-BB9B-44A6-9E1F-5AF823F143A9

P2860

Oncogenomics and the development of new cancer therapies

http://www.wikidata.org/entity/Q28263634

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Oncogenomics and the development of new cancer therapies

@ast

Oncogenomics and the development of new cancer therapies

@en

Oncogenomics and the development of new cancer therapies

@nl

type

label

Oncogenomics and the development of new cancer therapies

@ast

Oncogenomics and the development of new cancer therapies

@en

Oncogenomics and the development of new cancer therapies

@nl

prefLabel

Oncogenomics and the development of new cancer therapies

@ast

Oncogenomics and the development of new cancer therapies

@en

Oncogenomics and the development of new cancer therapies

@nl

P1433

Q28263634-F9642E2F-3115-4E65-ADFC-9F90DD65FB15

P1476

Q28263634-401C7A9B-8DFB-480E-B42A-370DAA46A52B

P2093

Q28263634-667E3E80-4385-4874-9A7D-BEE18C773865

Q28263634-7F5DDF4D-C94F-4ABB-B553-6E2D3829D54A

Q28263634-B5EAD9AA-A336-4C0D-BC27-9AFEEE04E64F

Q28263634-C6F82A17-04C4-4656-9FB4-FD718828C837

P2860

Q28263634-003801F2-4F43-4D0B-9A9A-C215CA114ABF

Q28263634-00BD5B13-37F6-455B-AEBC-BA30A06C7FC8

Q28263634-01566333-B009-49CC-8E4A-775E0E063C04

Q28263634-0196B011-6D32-476A-BDAC-424C83355D21

Q28263634-0276EDD4-2D67-4C69-BB22-152C5803E978

Q28263634-0484723C-3B0A-40C5-896E-382A28DCC4B5

Q28263634-04EF64FF-679F-4AEA-B07E-6CC8C890673F

Q28263634-07BF7930-8E5E-475B-88CF-EC4A48663B85

Q28263634-08A3297B-D70D-4365-8AC6-E1CCFC066C69

Q28263634-131979CA-1D96-4A34-AD41-890167364494

P2888

Q28263634-EF47F7AA-1C59-4F0B-A04D-B2E936F1336E

P304

Q28263634-CD7F6C9F-F32C-444A-BE02-20BE89837375

P31

Q28263634-7FDE5551-8D3C-4AC8-BE7C-EFDB4CDB4C18

P356

Q28263634-7D50034E-956B-44E7-879E-B386AA216D52

P407

Q28263634-F0CF54FF-C1EB-41AF-BA2C-15FAEA734D36

P433

Q28263634-A66F2B78-7B3C-4344-A6EB-F8E02AD22B60

P478

Q28263634-75C2BCD8-D0FD-41D8-A2C2-52FFAE78ACCA

P577

Q28263634-BBA2A202-9A94-46C9-B73D-DEE7D1AB7C4D

P5875

Q28263634-7E4411A5-7AEE-4F76-85F2-FA3721F3EDDD

P6179

Q28263634-ED31789C-EB68-41D4-8100-6CEBE49BD350

P698

Q28263634-AF5D712F-4137-41BD-9594-20035D47C3F1

P356

P1433

P1476

Oncogenomics and the development of new cancer therapies

@en

P2093

Andrew J G Simpson

http://www.w3.org/2001/XMLSchema#string

Gregory J Riggins

http://www.w3.org/2001/XMLSchema#string

Lloyd J Old

http://www.w3.org/2001/XMLSchema#string

Robert L Strausberg

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

Expression profiling predicts outcome in breast cancer

Complete sequencing and characterization of 21,243 full-length human cDNAs

The Sequence of the Human Genome

Digital karyotyping

Biodiversity hotspots for conservation priorities

NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients

1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis

P2888

P304

469-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE02627

http://www.w3.org/2001/XMLSchema#string

P407

P433

6990

http://www.w3.org/2001/XMLSchema#string

P478

429

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8542524

http://www.w3.org/2001/XMLSchema#string

P6179

1043851836

http://www.w3.org/2001/XMLSchema#string

P698

15164073

http://www.w3.org/2001/XMLSchema#string